ID   SMZ-1
AC   CVCL_RL84
SY   SMZ1
DR   cancercelllines; CVCL_RL84
DR   Cell_Model_Passport; SIDM01784
DR   DepMap; ACH-001197
DR   Wikidata; Q54955007
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1316225;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 34 hours (PubMed=1316225).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Phe113Ser (c.338T>C); ClinVar=VCV000823709; Zygosity=Unspecified (DepMap=ACH-001197).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   NCIt; C3466; T-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
DI   ORDO; Orphanet_171918; T-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//
RX   PubMed=1316225; DOI=10.1016/0165-4608(92)90215-T;
RA   Miyanishi S., Ohno H.;
RT   "Characterization of a novel T-cell lymphoma cell line established
RT   from a patient with systemic lupus erythematosus-associated
RT   lymphoma.";
RL   Cancer Genet. Cytogenet. 59:199-205(1992).
//